Literature DB >> 21723633

Function of erbB receptors and DNA-PKcs on phosphorylation of cytoplasmic and nuclear Akt at S473 induced by erbB1 ligand and ionizing radiation.

Mahmoud Toulany1, Tim-Andre Schickfluss, Kazi R Fattah, Kyung-Jong Lee, Benjamin P C Chen, Birgit Fehrenbacher, Martin Schaller, David J Chen, H Peter Rodemann.   

Abstract

BACKGROUND AND
PURPOSE: In the present study effect of erbB2 as well as DNA-PKcs on ionizing radiation (IR)- and erbB1 ligand-induced phosphorylation of Akt at S473 in cytoplasmic and nuclear fractions was investigated.
MATERIALS AND METHODS: DNA-PKcs proficient and deficient syngeneic colon carcinoma sublines of HCT116 and the glioblastoma cell lines MO59K and MO59J as well as the lung carcinoma cell line A549 were used. Akt-S473 phosphorylation was investigated in cells pre-treated with pharmacological inhibitors or transfected with siRNA by immunoprecipitation, Western blotting and confocal microscopy after different stimuli, i.e., ligands and IR.
RESULTS: IR-induced phosphorylation of Akt in both MO59K and MO59J cell lines but not in HCT116 cells was DNA-PKcs dependent. In A549 cells, IR-induced phosphorylation of nuclear Akt-S473 was dependent on erbB1, erbB2, and DNA-PKcs. EGF induced phosphorylation of nuclear Akt-S473 in a DNA-PKcs and erbB2 independent manner.
CONCLUSION: Data indicate that the function of DNA-PKcs on IR-induced Akt-S473 phosphorylation is cell line specific. IR-induced, but not EGF-induced phosphorylation of cytoplasmic and/or nuclear Akt-S473 is erbB2 dependent. Copyright Â
© 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21723633     DOI: 10.1016/j.radonc.2011.06.004

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  12 in total

Review 1.  DNA-PK: a dynamic enzyme in a versatile DSB repair pathway.

Authors:  Anthony J Davis; Benjamin P C Chen; David J Chen
Journal:  DNA Repair (Amst)       Date:  2014-03-27

Review 2.  Role of AKT signaling in DNA repair and clinical response to cancer therapy.

Authors:  Qun Liu; Kristen M Turner; W K Alfred Yung; Kexin Chen; Wei Zhang
Journal:  Neuro Oncol       Date:  2014-05-07       Impact factor: 12.300

Review 3.  Beyond DNA repair: DNA-PK function in cancer.

Authors:  Jonathan F Goodwin; Karen E Knudsen
Journal:  Cancer Discov       Date:  2014-08-28       Impact factor: 39.397

4.  Development and characterization of an isogenic cell line with a radioresistant phenotype.

Authors:  Lara I de Llobet; Marta Baro; Agnès Figueras; Ignasi Modolell; Maria V Da Silva; Purificación Muñoz; Arturo Navarro; Ricard Mesia; Josep Balart
Journal:  Clin Transl Oncol       Date:  2012-07-24       Impact factor: 3.405

5.  The influence of AKT isoforms on radiation sensitivity and DNA repair in colon cancer cell lines.

Authors:  Sara Häggblad Sahlberg; Ann-Sofie Gustafsson; Prathyusha N Pendekanti; Bengt Glimelius; Bo Stenerlöw
Journal:  Tumour Biol       Date:  2013-12-14

6.  Localisation Microscopy of Breast Epithelial ErbB-2 Receptors and Gap Junctions: Trafficking after γ-Irradiation, Neuregulin-1β, and Trastuzumab Application.

Authors:  Götz Pilarczyk; Ines Nesnidal; Manuel Gunkel; Margund Bach; Felix Bestvater; Michael Hausmann
Journal:  Int J Mol Sci       Date:  2017-02-09       Impact factor: 5.923

Review 7.  mTORC Inhibitors as Broad-Spectrum Therapeutics for Age-Related Diseases.

Authors:  Hannah E Walters; Lynne S Cox
Journal:  Int J Mol Sci       Date:  2018-08-08       Impact factor: 5.923

8.  Restraining Akt1 Phosphorylation Attenuates the Repair of Radiation-Induced DNA Double-Strand Breaks and Reduces the Survival of Irradiated Cancer Cells.

Authors:  Klaudia Szymonowicz; Sebastian Oeck; Adam Krysztofiak; Jansje van der Linden; George Iliakis; Verena Jendrossek
Journal:  Int J Mol Sci       Date:  2018-07-31       Impact factor: 5.923

9.  Dasatinib worsens the effect of cetuximab in combination with fractionated radiotherapy in FaDu- and A431-derived xenografted tumours.

Authors:  M Baro; L I de Llobet; A Figueras; I Skvortsova; R Mesia; J Balart
Journal:  Br J Cancer       Date:  2014-07-31       Impact factor: 7.640

10.  Proteomics and transcriptomics analyses of ataxia telangiectasia cells treated with Dexamethasone.

Authors:  Michele Menotta; Sara Orazi; Anna Maria Gioacchini; Chiara Spapperi; Anastasia Ricci; Luciana Chessa; Mauro Magnani
Journal:  PLoS One       Date:  2018-04-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.